The test can be used to detect HDV infection, a particularly dangerous coinfection that can occur with hepatitis B virus.

Medicare lab spending totaled $8.4 billion in 2024, up 5 percent year over year, with $3.6 billion of that spent on genetic testing, an increase of 20 percent over 2023.

The company is the first commercial lab in the US to agree to implement the system, which it will begin using in the first quarter of the year.

The firm attributed the increase in part to life sciences and diagnostics revenue that was better than expected.